Methotrexate

Methotrexate

PRODUCT Methotrexate inj.
COMPOSITION Each ml contains: Methotrexate 25 mg
INDICATIONS

Acute lymphocytic leukaemia, prophylaxis of meningeal leukaemia, Non-Hodgkin's lymphomas, osteogenic sarcoma, adjuvant and in advance disease of breast cancer, metastatic or recurrent head and neck cancer, choriocarcinoma and similar trophoblastic diseases, advanced cancer of urinary bladder.

PACKING TYPE 2 ml
MEDICINE TYPE Allopathic